Related references
Note: Only part of the references are listed.A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection
Rodrigo Rodrigues et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
A human gut ecosystem protects against C. difficile disease by targeting TcdA
Sarah Lynn Martz et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis
Nicole T. Shen et al.
GASTROENTEROLOGY (2017)
Effect of a national 4C antibiotic stewardship intervention CrossMazk on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis
Timothy Lawes et al.
LANCET INFECTIOUS DISEASES (2017)
Bezlotoxumab - A New Agent for Clostridium difficile Infection
John G. Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains
Susan Secore et al.
PLOS ONE (2017)
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France
Emilie Baro et al.
PLOS ONE (2017)
Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
Melanie L. Hutton et al.
SCIENTIFIC REPORTS (2017)
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
Jenessa A. Winston et al.
ANAEROBE (2016)
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
Colleen R. Kelly et al.
ANNALS OF INTERNAL MEDICINE (2016)
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
Kamal Desai et al.
BMC INFECTIOUS DISEASES (2016)
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
Ilan Youngster et al.
BMC MEDICINE (2016)
Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand
J. A. Trubiano et al.
INTERNAL MEDICINE JOURNAL (2016)
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection
Alexa R. Weingarden et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages
Janet Y. Nale et al.
FRONTIERS IN MICROBIOLOGY (2016)
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer
Lorena Valdes-Varela et al.
FRONTIERS IN MICROBIOLOGY (2016)
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
Christian Carlucci et al.
EBIOMEDICINE (2016)
Advances in the Microbiome: Applications to Clostridium difficile Infection
Eamonn P. Culligan et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
Lauren Lapointe-Shaw et al.
PLOS ONE (2016)
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth
Alexa R. Weingarden et al.
PLOS ONE (2016)
Clostridium difficile infection: a review of current and emerging therapies
Andrew Ofosu
ANNALS OF GASTROENTEROLOGY (2016)
A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management
Csaba Feher et al.
INFECTIOUS DISEASES AND THERAPY (2016)
Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection A Randomized Clinical Trial
Dale N. Gerding et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The potential use of cholestyramine to reduce the risk of developing Clostridium difficile-associated diarrhoea in patients receiving long-term intravenous ceftriaxone
B. K. Puri et al.
MEDICAL HYPOTHESES (2015)
The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection
Xingmin Sun et al.
MOLECULAR IMMUNOLOGY (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A small-molecule antivirulence agent for treating Clostridium difficile infection
Kristina Oresic Bender et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
Glen P. Carter et al.
MBIO (2015)
Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis
Gauree G. Konijeti et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2014)
Treatment of recurrent Clostridium difficile infection: a systematic review
J. C. O'Horo et al.
INFECTION (2014)
Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
Peter Orth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection A Systematic Review
Giovanni Cammarota et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias
Lena Novack et al.
PLOS ONE (2014)
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
Zain Kassam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
Carey-Ann D. Burnham et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
A New Strategy for the Prevention of Clostridium difficile Infection
Amber Howerton et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
Stephen J. Allen et al.
LANCET (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
Michael S. M. Brouwer et al.
NATURE COMMUNICATIONS (2013)
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Amit S. Chitnis et al.
JAMA INTERNAL MEDICINE (2013)
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut
Elaine O. Petrof et al.
MICROBIOME (2013)
Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea A Systematic Review and Meta-analysis
Bradley C. Johnston et al.
ANNALS OF INTERNAL MEDICINE (2012)
The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999-2007
Aron J. Hall et al.
CLINICAL INFECTIOUS DISEASES (2012)
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Oliver A. Comely et al.
CLINICAL INFECTIOUS DISEASES (2012)
Burden of Clostridium difficile on the Healthcare System
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2012)
Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis
R. Postigo et al.
INFECTION (2012)
Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea A Systematic Review and Meta-analysis
Susanne Hempel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients Methodology and Results
Colleen R. Kelly et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
Sahil Khanna et al.
MAYO CLINIC PROCEEDINGS (2012)
A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases
Marina L. Ritchie et al.
PLOS ONE (2012)
Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A
Lisa F. Dawson et al.
PLOS ONE (2012)
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
Kevin W. Garey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Mapping Interactions between Germinants and Clostridium difficile Spores
Amber Howerton et al.
JOURNAL OF BACTERIOLOGY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
Kate E. Dingle et al.
PLOS ONE (2011)
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
Les Dethlefsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Potential for Airborne Dispersal of Clostridium difficile from Symptomatic Patients
Emma L. Best et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Treatment of Refractory/Recurrent C-difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy A Case Series of 12 Patients
Sonia S. Yoon et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology
Faith Rohlke et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile
Jennifer L. Giel et al.
PLOS ONE (2010)
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
Brett A. Leav et al.
VACCINE (2010)
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Johan S. Bakken
ANAEROBE (2009)
Treatment of Clostridium difficile-Associated Disease
Daniel A. Leffler et al.
GASTROENTEROLOGY (2009)
Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
Mary Y. Hu et al.
GASTROENTEROLOGY (2009)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Sandra Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea
Christina M. Surawicz
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Increased sporulation rate of epidemic clostridium difficile type 027/NAP1
Thomas Akerlund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Clostridium difficile— More Difficult Than Ever
Ciarán P. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
Cecilia Jernberg et al.
ISME JOURNAL (2007)
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile -: Associated diarrhea
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2006)
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome
Mohammed Sebaihia et al.
NATURE GENETICS (2006)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
The outcome of surgery in fulminant Clostridium difficile colitis
K Koss et al.
COLORECTAL DISEASE (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Biofilms: the matrix revisited
SS Branda et al.
TRENDS IN MICROBIOLOGY (2005)
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
S Aslam et al.
LANCET INFECTIOUS DISEASES (2005)
In-vitro activity of nisin against clinical isolates of Clostridium difficile
A Bartoloni et al.
JOURNAL OF CHEMOTHERAPY (2004)
Probiotics to enhance anti-infective defences in the gastrointestinal tract
HS Gill
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
Share Paper
